Brain grey matter perfusion in primary progressive multiple sclerosis: Mild decrease over years and regional associations with cognition and hand function.
ASL
MRI
multiple sclerosis
neurodegeneration
perfusion
Journal
European journal of neurology
ISSN: 1468-1331
Titre abrégé: Eur J Neurol
Pays: England
ID NLM: 9506311
Informations de publication
Date de publication:
06 2022
06 2022
Historique:
received:
19
10
2021
accepted:
11
02
2022
pubmed:
16
2
2022
medline:
10
5
2022
entrez:
15
2
2022
Statut:
ppublish
Résumé
Extent and dynamic of neurodegeneration in progressive multiple sclerosis (MS) might be reflected by global and regional brain perfusion, an outcome at the intercept between structure and function. Here, we provide a first insight into the evolution of brain perfusion and its association with disability in primary progressive MS (PPMS) over several years. Seventy-seven persons with PPMS were followed over up to 5 years. Visits included a 3-T magnetic resonance imaging with pulsed arterial spin labelling perfusion, the Timed 25-Foot Walk, 9-Hole Peg Test (NHPT), Symbol Digit Modalities Test (SDMT), and Expanded Disability Status Scale (EDSS). We extracted regional cerebral blood flow surrogates and compared them to 11 controls. Analyses focused on cortical and deep grey matter, the change over time, and associations with disability on the regional and global levels. Baseline brain perfusion of patients and controls was comparable for the cortex (p = 0.716) and deep grey matter (p = 0.095). EDSS disability increased mildly (p = 0.023), whereas brain perfusion decreased during follow-up (p < 0.001) and with disease duration (p = 0.009). Lower global perfusion correlated with higher disability as indicated by EDSS, NHPT, and Timed 25-Foot Walk (p < 0.001). The motor task NHPT showed associations with 20 grey matter regions. In contrast, better SDMT performance correlated with lower perfusion (p < 0.001) in seven predominantly frontal regions, indicating a functional maladaptation. Decreasing perfusion indicates a putative association with MS disease mechanisms such as neurodegeneration, reduced metabolism, and loss of resilience. A low alteration rate limits its use in clinical practice, but regional association patterns might provide a snapshot of adaptive and maladaptive functional reorganization.
Sections du résumé
BACKGROUND AND PURPOSE
Extent and dynamic of neurodegeneration in progressive multiple sclerosis (MS) might be reflected by global and regional brain perfusion, an outcome at the intercept between structure and function. Here, we provide a first insight into the evolution of brain perfusion and its association with disability in primary progressive MS (PPMS) over several years.
METHODS
Seventy-seven persons with PPMS were followed over up to 5 years. Visits included a 3-T magnetic resonance imaging with pulsed arterial spin labelling perfusion, the Timed 25-Foot Walk, 9-Hole Peg Test (NHPT), Symbol Digit Modalities Test (SDMT), and Expanded Disability Status Scale (EDSS). We extracted regional cerebral blood flow surrogates and compared them to 11 controls. Analyses focused on cortical and deep grey matter, the change over time, and associations with disability on the regional and global levels.
RESULTS
Baseline brain perfusion of patients and controls was comparable for the cortex (p = 0.716) and deep grey matter (p = 0.095). EDSS disability increased mildly (p = 0.023), whereas brain perfusion decreased during follow-up (p < 0.001) and with disease duration (p = 0.009). Lower global perfusion correlated with higher disability as indicated by EDSS, NHPT, and Timed 25-Foot Walk (p < 0.001). The motor task NHPT showed associations with 20 grey matter regions. In contrast, better SDMT performance correlated with lower perfusion (p < 0.001) in seven predominantly frontal regions, indicating a functional maladaptation.
CONCLUSIONS
Decreasing perfusion indicates a putative association with MS disease mechanisms such as neurodegeneration, reduced metabolism, and loss of resilience. A low alteration rate limits its use in clinical practice, but regional association patterns might provide a snapshot of adaptive and maladaptive functional reorganization.
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1741-1752Informations de copyright
© 2022 European Academy of Neurology.
Références
Friese MA, Schattling B, Fugger L. Mechanisms of neurodegeneration and axonal dysfunction in multiple sclerosis. Nat Rev Neurol. 2014;10(4):225-238. doi:10.1038/nrneurol.2014.37
Wuerfel J. Changes in cerebral perfusion precede plaque formation in multiple sclerosis: a longitudinal perfusion MRI study. Brain. 2004;127(1):111-119. doi:10.1093/brain/awh007
Rashid W. Abnormalities of cerebral perfusion in multiple sclerosis. J Neurol Neurosurg Psychiatry. 2004;75(9):1288-1293. doi:10.1136/jnnp.2003.026021
Holland CM, Charil A, Csapo I, et al. The relationship between normal cerebral perfusion patterns and white matter lesion distribution in 1,249 patients with multiple sclerosis. J Neuroimaging. 2012;22(2):129-136. doi:10.1111/j.1552-6569.2011.00585.x
Lagana M, Pelizzari L, Baglio F. Relationship between MRI perfusion and clinical severity in multiple sclerosis. Neural Regen Res. 2020;15(4):646. doi:10.4103/1673-5374.266906
Eshaghi A, Marinescu RV, Young AL, et al. Progression of regional grey matter atrophy in multiple sclerosis. Brain J Neurol. 2018;141(6):1665-1677. doi:10.1093/brain/awy088
Steenwijk MD, Geurts JJG, Daams M, et al. Cortical atrophy patterns in multiple sclerosis are non-random and clinically relevant. Brain. 2016;139:115-126. doi:10.1093/brain/awv337
Paulson OB, Hasselbalch SG, Rostrup E, Knudsen GM, Pelligrino D. Cerebral blood flow response to functional activation. J Cereb Blood Flow Metab. 2010;30(1):2-14. doi:10.1038/jcbfm.2009.188
Debernard L, Melzer TR, Van Stockum S, et al. Reduced grey matter perfusion without volume loss in early relapsing-remitting multiple sclerosis. J Neurol Neurosurg Psychiatry. 2014;85(5):544-551. doi:10.1136/jnnp-2013-305612
Steen C, D'haeseleer M, Hoogduin JM, et al. Cerebral white matter blood flow and energy metabolism in multiple sclerosis. Mult Scler J. 2013;19(10):1282-1289. doi:10.1177/1352458513477228
Hahn A, Breakspear M, Rischka L, et al. Reconfiguration of functional brain networks and metabolic cost converge during task performance. eLife. 2020;9:e52443. doi:10.7554/eLife.52443
Williams DS, Detre JA, Leigh JS, Koretsky AP. Magnetic resonance imaging of perfusion using spin inversion of arterial water. Proc Natl Acad Sci. 1992;89(1):212-216. doi:10.1073/pnas.89.1.212
Inglese M, Adhya S, Johnson G, et al. Perfusion magnetic resonance imaging correlates of neuropsychological impairment in multiple sclerosis. J Cereb Blood Flow Metab. 2008;28(1):164-171. doi:10.1038/sj.jcbfm.9600504
Inglese M, Park SJ, Johnson G, et al. Deep gray matter perfusion in multiple sclerosis: dynamic susceptibility contrast perfusion magnetic resonance imaging at 3 T. Arch Neurol. 2007;64(2):196. doi:10.1001/archneur.64.2.196
Ota M, Sato N, Nakata Y, et al. Abnormalities of cerebral blood flow in multiple sclerosis: a pseudocontinuous arterial spin labeling MRI study. Magn Reson Imaging. 2013;31(6):990-995. doi:10.1016/j.mri.2013.03.016
Amann M, Achtnichts L, Hirsch JG, et al. 3D GRASE arterial spin labelling reveals an inverse correlation of cortical perfusion with the white matter lesion volume in MS. Mult Scler J. 2012;18(11):1570-1576. doi:10.1177/1352458512441984
Adhya S, Johnson G, Herbert J, et al. Pattern of hemodynamic impairment in multiple sclerosis: dynamic susceptibility contrast perfusion MR imaging at 3.0 T. NeuroImage. 2006;33(4):1029-1035. doi:10.1016/j.neuroimage.2006.08.008
Polman CH, Reingold SC, Banwell B, et al. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol. 2011;69(2):292-302. doi:10.1002/ana.22366
Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology. 1983;33(11):1444. doi:10.1212/WNL.33.11.1444
Polman CH, Rudick RA. The multiple sclerosis functional composite: a clinically meaningful measure of disability. Neurology. 2010;74(Issue 17, Supplement 3):S8-S15. doi:10.1212/WNL.0b013e3181dbb571
Cohen JA, Reingold SC, Polman CH, Wolinsky JS. Disability outcome measures in multiple sclerosis clinical trials: current status and future prospects. Lancet Neurol. 2012;11(5):467-476. doi:10.1016/S1474-4422(12)70059-5
Smith A. Symbol Digit Modalities Test (SDMT). Manual (Revised). Published Online 1982. Western Psychological Services.
Smith A. Symbol Digit Modalities Test (SDMT). Published Online 1991. Western Psychological Services.
Reuter M, Schmansky NJ, Rosas HD, Fischl B. Within-subject template estimation for unbiased longitudinal image analysis. NeuroImage. 2012;61(4):1402-1418. doi:10.1016/j.neuroimage.2012.02.084
Desikan RS, Ségonne F, Fischl B, et al. An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest. NeuroImage. 2006;31(3):968-980. doi:10.1016/j.neuroimage.2006.01.021
Avants BB, Duda JT, Kilroy E, et al. The pediatric template of brain perfusion. Sci Data. 2015;2(1):150003. doi:10.1038/sdata.2015.3
Isensee F, Schell M, Pflueger I, et al. Automated brain extraction of multisequence MRI using artificial neural networks. Hum Brain Mapp. 2019;40(17):4952-4964. doi:10.1002/hbm.24750
Lu H, Clingman C, Golay X, van Zijl PCM. Determining the longitudinal relaxation time (T1) of blood at 3.0 Tesla. Magn Reson Med. 2004;52(3):679-682. doi:10.1002/mrm.20178
Weinshenker BG, Issa M, Baskerville J. Meta-analysis of the placebo-treated groups in clinical trials of progressive MS. Neurology. 1996;46(6):1613-1619. doi:10.1212/wnl.46.6.1613
Ontaneda D, Thompson AJ, Fox RJ, Cohen JA. Progressive multiple sclerosis: prospects for disease therapy, repair, and restoration of function. Lancet Lond Engl. 2017;389(10076):1357-1366. doi:10.1016/S0140-6736(16)31320-4
Wickham H, Averick M, Bryan J, et al. Welcome to the tidyverse. J Open Source Softw. 2019;4(43):1686. doi:10.21105/joss.01686
Bates D, Mächler M, Bolker B, Walker S. Fitting linear mixed-effects models using lme4. J Stat Softw. 2015;67(1):1-48. doi:10.18637/jss.v067.i01
Mowinckel AM, Vidal-Piñeiro D. Visualization of brain statistics with R packages ggseg and ggseg3d. Adv Methods Pract Psychol Sci. 2020;3(4):466-483. doi:10.1177/2515245920928009
Mulholland AD, Vitorino R, Hojjat SP, et al. Spatial correlation of pathology and perfusion changes within the cortex and white matter in multiple sclerosis. Am J Neuroradiol. 2018;39(1):91-96. doi:10.3174/ajnr.A5410
Bester M, Forkert ND, Stellmann JP, et al. Increased perfusion in normal appearing white matter in high inflammatory multiple sclerosis patients. Cercignani M, ed. PLoS One. 2015;10(3):e0119356. doi:10.1371/journal.pone.0119356
Petersen ET, Mouridsen K, Golay X. The QUASAR reproducibility study, Part II: results from a multi-center Arterial Spin Labeling test-retest study. NeuroImage. 2010;49(1):104-113. doi:10.1016/j.neuroimage.2009.07.068
Saindane AM, Law M, Ge Y, Johnson G, Babb JS, Grossman RI. Correlation of diffusion tensor and dynamic perfusion MR imaging metrics in normal-appearing corpus callosum: support for primary hypoperfusion in multiple sclerosis. AJNR Am J Neuroradiol. 2007;28(4):767-772.
D'haeseleer M, Beelen R, Fierens Y, et al. Cerebral hypoperfusion in multiple sclerosis is reversible and mediated by endothelin-1. Proc Natl Acad Sci. 2013;110(14):5654-5658. doi:10.1073/pnas.1222560110
Monti L, Morbidelli L, Rossi A. Impaired cerebral perfusion in multiple sclerosis: relevance of endothelial factors. Biomark Insights. 2018;13:117727191877480. doi:10.1177/1177271918774800
Marshall O, Lu H, Brisset JC, et al. Impaired cerebrovascular reactivity in multiple sclerosis. JAMA Neurol. 2014;71(10):1275. doi:10.1001/jamaneurol.2014.1668
Sivakolundu DK, West KL, Maruthy GB, et al. Reduced arterial compliance along the cerebrovascular tree predicts cognitive slowing in multiple sclerosis: evidence for a neurovascular uncoupling hypothesis. Mult Scler J. 2020;26(12):1486-1496. doi:10.1177/1352458519866605
Sivakolundu DK, West KL, Zuppichini M, et al. The neurovascular basis of processing speed differences in humans: a model-systems approach using multiple sclerosis. NeuroImage. 2020;215:116812. doi:10.1016/j.neuroimage.2020.116812
Lavery AM, Verhey LH, Waldman AT. Outcome measures in relapsing-remitting multiple sclerosis: capturing disability and disease progression in clinical trials. Mult Scler Int. 2014;2014:1-13. doi:10.1155/2014/262350
Feys P, Lamers I, Francis G, et al. The Nine-Hole Peg test as a manual dexterity performance measure for multiple sclerosis. Mult Scler J. 2017;23(5):711-720. doi:10.1177/1352458517690824
Battaglia-Mayer A, Caminiti R. Parieto-frontal networks for eye-hand coordination and movements. In Vallar G, Coslett HB, eds. Handbook of Clinical Neurology. Elsevier; 2018;151:499-524. doi:10.1016/B978-0-444-63622-5.00026-7
Grill-Spector K, Malach R. The human visual cortex. Annu Rev Neurosci. 2004;27(1):649-677. doi:10.1146/annurev.neuro.27.070203.144220
Zhong J, Chen DQ, Nantes JC, Holmes SA, Hodaie M, Koski L. Combined structural and functional patterns discriminating upper limb motor disability in multiple sclerosis using multivariate approaches. Brain Imaging Behav. 2017;11(3):754-768. doi:10.1007/s11682-016-9551-4
Has Silemek AC, Fischer L, Pöttgen J, et al. Functional and structural connectivity substrates of cognitive performance in relapsing remitting multiple sclerosis with mild disability. NeuroImage Clin. 2020;25:102177. doi:10.1016/j.nicl.2020.102177
Rocca MA, Valsasina P, Absinta M, et al. Default-mode network dysfunction and cognitive impairment in progressive MS. Neurology. 2010;10:1252-1259.
Forn C, Rocca MA, Boscá I, Casanova B, Sanjuan A, Filippi M. Analysis of “task-positive” and “task-negative” functional networks during the performance of the Symbol Digit Modalities Test in patients at presentation with clinically isolated syndrome suggestive of multiple sclerosis. Exp Brain Res. 2013;225(3):399-407. doi:10.1007/s00221-012-3380-5
Gevers S, van Osch MJ, Bokkers RP, et al. Intra- and multicenter reproducibility of pulsed, continuous and pseudo-continuous arterial spin labeling methods for measuring cerebral perfusion. J Cereb Blood Flow Metab. 2011;31(8):1706-1715. doi:10.1038/jcbfm.2011.10
López-Góngora M, Querol L, Escartín A. A one-year follow-up study of the symbol digit modalities test (SDMT) and the paced auditory serial addition test (PASAT) in relapsing-remitting multiple sclerosis: an appraisal of comparative longitudinal sensitivity. BMC Neurol. 2015;15(1):40. doi:10.1186/s12883-015-0296-2
Hyland M, Rudick RA. Challenges to clinical trials in multiple sclerosis: outcome measures in the era of disease-modifying drugs. Curr Opin Neurol. 2011;24(3):255-261. doi:10.1097/WCO.0b013e3283460542